Amylin Pharmaceuticals (AMLN) Posts Narrower than Expected Q1 Loss of 23c/Share
Tweet Send to a FriendGet Alerts AMLN Hot Sheet
Price: $30.98 --0%
EPS Growth %: +4.2%
Financial Fact:
Total revenues: 153.69M
Today's EPS Names:
CEDU, CHC, CIDM, More
EPS Growth %: +4.2%
Financial Fact:
Total revenues: 153.69M
Today's EPS Names:
CEDU, CHC, CIDM, More
Trade AMLN Now!
Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) reported Q1 EPS of ($0.23), $0.06 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $153.7 million versus the consensus estimate of $161.66 million.
For earnings history and earnings-related data on Amylin Pharmaceuticals, Inc. (AMLN) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Amylin Pharmaceuticals, Inc. (AMLN) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jabil Circuit (JBL) Tops Q3 EPS by 2c; Issues Light Q4 Outlook; Will Realign Global Ops
- Red Hat, Inc. (RHT) Tops Q1 EPS by 1c
- Finisar Corp (FNSR) Tops Q4 EPS by 3c; Guides Q1 EPS Above Views
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
